Shandong Kanglida Medical Products Co., Ltd., established on 2002-08-12, Business scope includes licensed projects:Production of hygiene products and single-use medical products;Cosmetic production;Production of Class II Medical Devices;Class III medical device business;Production of sterile equipment;Production of protective equipment for medical personnel(Class II medical device);Class Ι Radioactive Source Sales;Production of disinfection products for the prevention and control of infectious diseases;Radiological Health Technical Services;Disinfectant production(Free of Hazardous Chemicals);pharmaceutical production;Internet information service;Import and export.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments,The specific business items are subject to the approval documents or licenses of relevant departments)General project:Production of Class I Medical Devices;Sales of Class I Medical Devices;Sales of Class II Medical Devices;Sales of hygiene products and single-use medical products;Disinfectant sales(Free of Hazardous Chemicals);Sales of special labor protection products;software development;Cosmetics Wholesale;Cosmetics Retail;Personal Hygiene Sales;internet sales(Except for products that require a license for sale);Technical Services,technology development,technical consulting,Technology Exchange,technology transfer,Technology Promotion;Sales of labor protection products;Manufacture of technical textile products;Sporting Goods and Equipment Retailing;Sports goods and equipment manufacturing;musical instrument manufacturing;Musical instrument spare parts sales.(Except for projects subject to approval by law,Carry out business activities independently in accordance with the law with a business license)

Siao Biotechnology Suzhou Co. Ltd. is a company headquartered in Suzhou, China, that engages in the research and development and production of veterinary, aquatic vaccines and pesticides. The firm was founded in 2012.

Novavax is a biotechnology company that promotes improved health globally through the discovery, development, and commercialization of innovative vaccines to prevent serious infectious diseases. Novavax recently initiated the development of NVX-CoV2373, its vaccine candidate against SARS-CoV-2, the virus that causes COVID-19, with Phase 1 clinical trial results expected in July 2020. NanoFlu™, its quadrivalent influenza nanoparticle vaccine, met all primary objectives in its pivotal Phase 3 clinical trial in older adults. Both vaccine candidates incorporate Novavax’s proprietary saponin-based Matrix-M™ adjuvant in order to enhance the immune response and stimulate high levels of neutralizing antibodies. Novavax is a leading innovator of recombinant vaccines; its proprietary recombinant technology platform combines the power and speed of genetic engineering to efficiently produce highly immunogenic nanoparticles in order to address urgent global health needs.

The Boyce Thompson Institute (previously: Boyce Thompson Institute for Plant Research) is an independent research institute devoted to using plant sciences to improve agriculture, protect the environment, and enhance human health. BTI is located on the campus of Cornell University in Ithaca, New York, United States, and is fully integrated in the research infrastructure of the University. Faculty at BTI are members of several Cornell Departments, including Plant Biology, Chemistry & Chemical Biology, Molecular Biology & Genetics, as well as Plant Pathology and Plant-Microbe Biology. BTI is governed by a Board of Directors, which is in part appointed by Cornell.

San Heh Pharmaceutical Corp. is a Taiwanese private company located in Kaohsiung City. The firm engages in feed manufacturing industry.

Merck (d.b.a. EMD Millipore in the U.S. and Canada) is a German chemical and pharmaceutical company. Merck, also known as “German Merck” and “Merck Darmstadt”, was founded in Darmstadt, Germany, in 1668, making it the world's oldest operating chemical and pharmaceutical company. The company was privately owned until going public in 1995. However, the Merck family still controls a majority (≈70%) of the company's shares. Following World War I, Merck lost possession of its foreign sites, including the Merck & Co. subsidiary in the United States. Merck & Co., which operates as Merck Sharp and Dohme (MSD) outside the U.S. and Canada, is now an independent company. Merck KGaA operates mainly in Europe, Africa, Asia, Oceania and Latin America. Since Merck & Co. holds the rights to the Merck name in the U.S. and Canada, the company operated under the umbrella brand EMD Chemicals in North America, and since 2010 as EMD Millipore (after the acquisition of Millipore Corporation), formed from the initials of Emanuel Merck, Darmstadt. Founded in 1668 in Darmstadt, Merck KGaA of Darmstadt, Germany, is the world's oldest pharmaceutical and chemical company. The success of the export business to the United States led in 1887 to the establishment of an office in New York, which gave rise to their subsidiary [Merck & Co.](http://www.crunchbase.com/organization/merck-co-inc) four years later. Owing to World War I, Merck & Co. was expropriated in 1917. The two companies have been separate every since. Merck KGaA Subsidiaries: - [Merck Consumer Healthcare](http://www.crunchbase.com/organization/merck-consumer-healthcare) - [Merck Performance Materials](http://www.crunchbase.com/organization/merck-performance-materials)

Beijing Kemufeng Biopharmaceutical Co., Ltd., established on 2012-04-23, The scope of business includes the production of veterinary drugs;sales of veterinary drugs;Bioengineering technology development;technology development,transfer,consult,Serve;Sales of medical devices(Ι,Class II),Instrumentation;Import and export;Technology Import and Export;Agent import and export.(Market entities independently choose business projects in accordance with the law,Carry out business activities;and items that are legally subject to approval,Carry out business activities in accordance with the approved content after approval by relevant departments;Do not engage in the business activities of projects prohibited and restricted by the industrial policies of the state and this city.)

Nanjing Tianbang Bio Technology Co., Ltd., part of Beijing Dabeinong Technology Group Co., Ltd., is a Chinese company located in Nanjing. The firm engages in researching and developing animal bio products. On March 12, 2014 Beijing Dabeinong Technology Group Co., Ltd. acquired Nanjing Tianbang Bio Technology Co., Ltd. for $1.94 million.

Zhaofenghua Biotechnology (Nanjing) Co., Ltd. Beijing Biomedical Technology Center, established on 2019-12-19, Business scope includes bioengineering technology development:Technical Services,technical consulting,technology transfer,Technology Promotion;Development of diagnosis and treatment technology for animal diseases,consult,transfer,Serve.(Market entities independently choose business projects in accordance with the law,Carry out business activities;Items subject to approval by law,Carry out business activities in accordance with the approved content after approval by relevant departments;Do not engage in the business activities of projects prohibited and restricted by the industrial policies of the state and this city.)

Hangke China Investment Biotechnology (Beijing) Co., Ltd., established on 2016-09-30, Business scope includes technical consulting,Technical Services,technology transfer;Medical Research and Experimental Development;Technology Import and Export;Sales of medical devices(limit Ι,Class II),hygiene products,Disinfectant(Free of Hazardous Chemicals),electronic product,stationery,household appliances,clothing,daily necessities,communication equipment,Computer software and auxiliary equipment,Equipment,hardware products(E-bike not included),Knitting Supplies,cleaning supplies;Import and export;Agent import and export;Production of Class I medical devices;sell food;Sales of Class III Medical Devices;Production of Class II medical devices.(Market entities independently choose business projects in accordance with the law,Carry out business activities;sell food,Production of Class II medical devices,Sales of Class III medical devices and items subject to approval according to law,Carry out business activities in accordance with the approved content after approval by relevant departments;Do not engage in the business activities of projects prohibited and restricted by the industrial policies of the state and this city.)

Pulike Biological Engineering, Inc. engages in the research, development, manufacturing and sale of biological products for animals, chemical drugs and Chinese veterinary drugs. Its products include genetic engineering vaccines and multivalent vaccines. The company also provides technical services. Pulike Biological Engineering was founded in 1995 and is headquartered in Luoyang, China.

Zhaofenghua Biotechnology (Fuzhou) Co., Ltd., established on 2003-05-26, Business scope includes technical development of biological products,Technical Services,Technology Transfer and Technology Consulting;Medical Research and Experimental Development;Agricultural Science Research and Experimental Development;Biopharmaceutical Manufacturing;Genetically engineered drugs and vaccine manufacturing.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments)

Part of Lantheus Holdings, Inc., Progenics Pharmaceuticals Nevada, Inc. is a company headquartered in the United States that manufactures pharmaceutical products.

Jilin Teyan Biotechnology Co., Ltd., established on 2009-08-10, Business scope includes veterinary biological products,Research and development of animal health products,technical consulting,Technical Services;Cytotoxic Suspension Culture Live Vaccine Production,Production of live cytotoxic vaccines,Cytotoxic inactivated vaccine production,Bacterial Inactivated Vaccine Production(The veterinary drug production license is valid until2024year1moon7day);Technical consultation on animal disease prevention and control,Technical Services;Enterprises use their own funds to invest abroad(Not to engage in deposit taking,Loans,Entrusted to issue loans,Valet financial,Financing guarantee and other financial services,Illegal fundraising is strictly prohibited);Import and export of goods and technology(Except for publication import business and goods and technologies that are restricted by the state or prohibited from import and export);General cargo(Does not contain flammable, explosive and precursor dangerous chemicals);Feed and Feed Additives,Sales of Veterinary Drugs*(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments).

Beijing Wantai is a manufacturer of infectious disease diagnostics. It operates domestic and international diagnostic test businesses in the fields of human infectious diseases and screening of blood donors. Its customers are blood banks, hospitals and clinics, reference laboratories, border inspection centers, blood-processing companies, and research institutes. Innovax is a separate division of Wantai that focuses on the development and commercialization of recombinant vaccines. Innovax's flagship product Hecolin, is the world's first launched Hepatitis E vaccine. Its production facilities are GMP, ISO9001 and ISO13485 certified. Founded in 1991, Beijing Wantai is headquartered in Beijing, China.

Medigen, Inc. is an American private company. The firm develops and commercializes vaccines for infectious & chronic diseases and cancer.\nThe company says this about itself: Medigen Inc., is a biopharmaceutical and CDMO company developing proprietary vaccines for emerging diseases. Medigen also serves as a Contract Development and Manufacturing Organization (CDMO) to manufacture vaccine-related products including cell banks, virus banks, live-attenuated, and vectored vaccines for our customers. The company is located in Frederick, Maryland.

JCR Pharmaceuticals Co., Ltd. engages in the manufacture and sale of pharmaceutical products. It operates through the following segments: Pharmaceutical Business; and Medical and Research Equipment Business. The Pharmaceutical Business segment deals with the manufacture, purchase, and sale of ethical drugs, active pharmaceutical ingredients, and raw materials. The Medical and Research Equipment Business segment sells medical devices and laboratory equipment. The company was founded by Shin Ashida on September 13, 1975 and is headquartered in Ashiya, Japan.

Shanghai Zhouyue Biotechnology Co., Ltd., established on 2014-09-19, Business scope includes technology development in the field of biotechnology,technical consulting,technology transfer,Technical Services. [Items subject to approval by law,Business activities can only be carried out after approval by relevant departments]